Filing Flows › Sanofi (SNY) › Q3 2025
Sanofi (SNY) Q3 2025 earnings results (third quarter 2025)
6-K filed Oct 24, 2025
Sanofi (SNY) reported revenue of $12.4B for the third quarter 2025 (Q3 2025), +2% from a year earlier and +24% from the quarter before. Operating margin was 29.1%, net earnings $2.8B (22.5% of revenue).
Sanofi, Q3 2025: revenue $12.4B (+2% year over year), operating margin 29.1%, net earnings $2.8B, operating cash flow $3.8B. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.4B | +24% | +2% |
| Gross profit | $9.8B | +26% | +5% |
| Operating profit | $3.6B | +146% | +2% |
| Net earnings | $2.8B | -29% | -0.5% |
| Operating cash flow | $3.8B | — | — |
What changed
Revenue was €12.4B in Q3 2025, up 2% year over year and up 24% from the previous quarter.
Gross margin was 78.5%, up 1.9 points from a year earlier. Operating profit was €3.6B, a 29.1% margin (unchanged year over year). Of the extra revenue versus a year earlier, 30% reached operating profit, above the 29% margin then. Operating expenses grew 6% against revenue growth of 2%. Net earnings were €2.8B, roughly flat year over year. The effective tax rate was 19.5%.
Operating cash flow was €3.8B, 134% of net earnings. Working capital and other items added €0.94B.
Questions
What was Sanofi's revenue in the third quarter 2025?
Sanofi (SNY) reported revenue of $12.4B for the third quarter 2025 (Q3 2025), +2% from a year earlier and +24% from the quarter before.
Was Sanofi profitable in the third quarter 2025?
Operating profit was $3.6B (29.1% of revenue) and net earnings $2.8B.
Source: Sanofi 6-K on SEC EDGAR.